Santa Rosa Antibiotic Effectiveness Project, Inc.

BACKGROUND

Barry N. Silberg, M.D., F.A.C.S., is the Executive Director of the Santa Rosa Antibiotic Effectiveness Project, Inc., and is the investigator-sponsor of the current study.
more

treatment

A promising new treatment for soft tissue infection, including Methicillin-resistant Staphylococcus Aureus (MRSA).
more

CURRENT STUDY

An FDA and WIRB approved expanded access study is currently in progress at Palm Drive Hospital, Sebastopol, California.
more

welcome

Promising new technology

The Santa Rosa Antibiotic Effectiveness Project is a 501(c)(3) nonprofit corporation that has been formed to advance the science of antibiotic medicine and to educate the public about our research in antibiotic effectiveness, which will benefit individuals and the community.

A study for direct antibiotic delivery, which offers a promising new way to treat soft tissue infections, including Methicillin-resistant Staphylococcus Aureus (MRSA), was approved on January 14, 2014, and is currently in progress at Palm Drive Hospital, 501 Petaluma Avenue, Sebastopol, California 95472. Treating physicians may contact the Palm Drive Hospital Wound Care Center at (707) 823-8511.

.

more

recent news

FDA and Western Institutional Review Board (WIRB) approves new Expanded Access Study - Intermediate Population at Palm Drive Hospital, 501 Petaluma Avenue, Sebastopol, California.

 

Clinical study approved by WIRB at Santa Rosa Memorial Hospital, 1165 Montgomery Drive, Santa Rosa, CA 95405.

Phase I Pilot Study completed and additional testing in lab with MRSA cultures based on Phase I findings.
Palm Drive Hospital, Sebastopol, California, now screening patients, for whom standard treatment therapy has failed, for an FDA and WIRB approved expanded access study - intermediate population for treatment of soft tissue infections using direct antibiotic delivery. Treating physicians should contact the Wound Care Center at (707) 823-8511.
Off-label use approved by Santa Rosa Memorial Hospital.

Phase I Pilot Study approved by Santa Rosa Memorial Hospital Investigational Review Board.